EWTX Operating Cash Flow (Statement)
Edgewise Therapeutics Inc · Operating Cash Flow (Statement)
EWTX Operating Cash Flow (Statement)
Latest reported-$43.51Mperiod ending
EWTX Quarterly Cash from Operations (-$2.74M → -$43.51M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
EWTX operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -43,510,000 | |
| -42,543,000 | |
| -38,592,000 | |
| -34,776,000 | |
| -32,582,000 | |
| -37,866,000 | |
| -26,957,000 | |
| -27,374,000 | |
| -26,099,000 | |
| -28,598,000 | |
| -26,830,000 | |
| -22,058,000 | |
| -20,234,000 | |
| -22,826,000 | |
| -11,820,000 | |
| -11,998,000 | |
| -16,245,000 | |
| -12,572,000 | |
| -9,419,000 | |
| -8,262,000 | |
| -9,769,000 | |
| -6,057,000 | |
| -4,638,000 | |
| -3,272,000 | |
| -3,985,000 | |
| -2,739,000 |